Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22480 | 24525254 | Clin Biochem | The relationship of serum uric acid with non-alcoholic fatty liver disease. | 2014 | Details |
| A22484 | 24521867 | Exp Anim | Fibroblast growth factor-5 participates in the progression of hepatic fibrosis. | 2014 | Details |
| A22488 | 24520400 | PLoS One | Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. | 2014 | Details |
| A22489 | 24520264 | Exp Ther Med | Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. | 2013 | Details |
| A22503 | 24512822 | J Hepatol | Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. | 2013 | Details |
| A22515 | 24498332 | PLoS One | Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A22517 | 24497882 | Hepat Mon | Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies. | 2014 | Details |
| A22524 | 24492282 | Lab Invest | Increased expression of c-Jun in nonalcoholic fatty liver disease. | 2014 | Details |
| A22530 | 24489722 | PLoS One | Cigarette smoke toxins deposited on surfaces: implications for human health. | 2014 | Details |
| A22533 | 24486698 | Mol Cell Endocrinol | Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. | 2014 | Details |
| A22538 | 24481324 | Endocr Relat Cancer | Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence. | 2014 | Details |
| A22547 | 24474231 | Arq Gastroenterol | Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery. | 2014 | Details |
| A22550 | 24471572 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. | 2014 | Details |
| A22553 | 24466347 | PLoS One | Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice. | 2014 | Details |
| A22556 | 24464211 | Dig Dis Sci | OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease. | 2014 | Details |
| A22558 | 24463897 | Arq Bras Cir Dig | Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity. | 2013 | Details |
| A22559 | 24463697 | Eur Radiol | Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. | 2014 | Details |
| A22565 | 24460502 | Gynecol Endocrinol | Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. | 2014 | Details |
| A22573 | 24454937 | PLoS One | Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis. | 2014 | Details |
| A22575 | 24452634 | Curr Gastroenterol Rep | Utilization of FibroScan in clinical practice. | 2014 | Details |
| A22582 | 24445215 | J Hepatol | Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22583 | 24445049 | J Nutr Biochem | Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis. | 2013 | Details |
| A22589 | 24440936 | J Clin Gastroenterol | Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. | 2015 | Details |
| A22598 | 24428677 | Expert Opin Pharmacother | New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. | 2014 | Details |
| A22599 | 24426199 | Indian J Clin Biochem | Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression. | 2012 | Details |
| A22601 | 24424317 | Int J Mol Sci | Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis C. | 2014 | Details |
| A22609 | 24417250 | Aliment Pharmacol Ther | PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. | 2014 | Details |
| A22612 | 24415281 | Obes Surg | Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation. | 2014 | Details |
| A22613 | 24412930 | Eur J Endocrinol | Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A22617 | 24407920 | Diabetologia | The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial. | 2014 | Details |
| A22623 | 24402126 | Int J Mol Sci | Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. | 2014 | Details |
| A22625 | 24401715 | Am J Clin Nutr | Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. | 2014 | Details |
| A22633 | 24395441 | J Cell Physiol | Protective effect of the Y220C mutant p53 against steatosis: good news? | 2014 | Details |
| A22642 | 24388885 | J Physiol Pharmacol | Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22666 | 24375485 | Hepatology | Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2013 | Details |
| A22685 | 25960770 | Diabetol Metab Syndr | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22689 | 25911911 | Eksp Klin Gastroenterol | [Hepatic parenchimatous damage and perfusion disturbance in the progression of nonalcoholic fatty liver disease]. | 2014 | Details |
| A22702 | 25763333 | Anal Cell Pathol (Amst) | Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease. | 2014 | Details |
| A22705 | 24368431 | J Nutr | Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. | 2013 | Details |
| A22706 | 24367597 | PLoS One | Therapy of experimental NASH and fibrosis with galectin inhibitors. | 2013 | Details |
| A22708 | 24365744 | Transl Res | Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. | 2013 | Details |
| A22710 | 24365277 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. | 2013 | Details |
| A22717 | 24360992 | J Pediatr | Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. | 2013 | Details |
| A22727 | 24353357 | Clin Biochem Rev | The de ritis ratio: the test of time. | 2013 | Details |
| A22732 | 24349208 | PLoS One | Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. | 2013 | Details |
| A22733 | 24349054 | PLoS One | No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. | 2013 | Details |
| A22740 | 24342745 | Clin Gastroenterol Hepatol | Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22745 | 24335903 | J Clin Gastroenterol | Liver function breath tests for differentiation of steatohepatitis from simple fatty liver in patients with nonalcoholic Fatty liver disease. | 2014 | Details |
| A22749 | 24333254 | Arch Med Res | Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease. | 2013 | Details |
| A22753 | 24329600 | J Gastroenterol Hepatol | Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. | 2014 | Details |
| A22763 | 24324749 | PLoS One | Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis. | 2013 | Details |
| A22768 | 24321532 | J Pediatr | Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
| A22774 | 24316747 | Acta Cir Bras | The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors. | 2013 | Details |
| A22775 | 24316518 | J Hepatol | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | 2013 | Details |
| A22779 | 24313922 | Liver Int | Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22782 | 24308774 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments. | 2013 | Details |
| A22791 | 24302697 | Pediatr Obes | Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity? | 2013 | Details |
| A22801 | 24294355 | Int J Clin Exp Pathol | Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. | 2013 | Details |
| A22803 | 24292310 | Mymensingh Med J | Histological scoring and associated risk factors of non-alcoholic fatty liver disease. | 2013 | Details |
| A22805 | 24291241 | J Hepatol | Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22813 | 26202292 | Hepatol Int | Current histological classification of NAFLD: strength and limitations. | 2013 | Details |
| A22814 | 26202291 | Hepatol Int | Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A22818 | 24298175 | Clin Med (Lond) | Repair-associated inflammation in nonalcoholic fatty liver disease. | 2013 | Details |
| A22819 | 24287794 | Endocrine | Non-alcoholic fatty liver disease: a diabetologist's perspective. | 2013 | Details |
| A22827 | 24280139 | Folia Biol (Praha) | Histological evaluation of the role of atypical antipsychotic drugs in inducing non-alcoholic fatty liver disease in adult male albino rats (light and electron microscopic study). | 2013 | Details |
| A22829 | 24277052 | J Gastroenterol | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. | 2013 | Details |
| A22830 | 24275855 | Curr Opin Oncol | Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. | 2014 | Details |
| A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
| A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22846 | 24274866 | Clin Liver Dis | The role of medications for the management of patients with NAFLD. | 2013 | Details |
| A22848 | 24274863 | Clin Liver Dis | The impact of obesity on liver histology. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |
| A22856 | 24251707 | J Gastroenterol Hepatol | Characteristics and diagnosis of NAFLD/NASH. | 2013 | Details |
| A22865 | 24267865 | Liver Int | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. | 2013 | Details |
| A22870 | 24264333 | Chest | Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. | 2014 | Details |
| A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
| A22877 | 24259972 | World J Gastroenterol | Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? | 2013 | Details |
| A22880 | 24258517 | Semin Immunopathol | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22881 | 24256559 | Liver Int | Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. | 2013 | Details |
| A22882 | 24256515 | Clin Endocrinol (Oxf) | Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2013 | Details |
| A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
| A22885 | 24254368 | Hepatology | The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. | 2014 | Details |
| A22887 | 24252302 | Biomark Res | Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. | 2013 | Details |
| A22900 | 24223115 | PLoS One | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A22903 | 24222941 | World J Gastroenterol | PNPLA3 I148M polymorphism and progressive liver disease. | 2013 | Details |
| A22905 | 24222094 | Semin Liver Dis | PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. | 2013 | Details |
| A22915 | 24215040 | Scott Med J | An epidemiological study of the association of coffee with chronic liver disease. | 2013 | Details |
| A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22925 | 24206433 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. | 2013 | Details |
| A22939 | 24190226 | Int J Mol Med | Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. | 2013 | Details |
| A22943 | 24188280 | Lipids Health Dis | Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet. | 2013 | Details |
| A22954 | 24179614 | World J Hepatol | Lipotoxicity in the liver. | 2013 | Details |
| A22962 | 24172912 | Eur J Gastroenterol Hepatol | Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22968 | 24161595 | Exp Mol Pathol | Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. | 2013 | Details |
| A22971 | 24157968 | Am J Physiol Gastrointest Liver Physiol | Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis. | 2013 | Details |